Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient.

The global HLA Antigen Typing and Antibody Detection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

The latest research report from ReportPrime, the “HLA Antigen Typing and Antibody Detection Industry Forecast” looks at past sales and reviews total world HLA Antigen Typing and Antibody Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected HLA Antigen Typing and Antibody Detection sales for 2023 through 2029.

• With HLA Antigen Typing and Antibody Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HLA Antigen Typing and Antibody Detection industry.

This Insight Report provides a comprehensive analysis of the global HLA Antigen Typing and Antibody Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on HLA Antigen Typing and Antibody Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HLA Antigen Typing and Antibody Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HLA Antigen Typing and Antibody Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

United States market for HLA Antigen Typing and Antibody Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for HLA Antigen Typing and Antibody Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for HLA Antigen Typing and Antibody Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key HLA Antigen Typing and Antibody Detection players cover:

• Abbott
• Siemens
• Roche
• Thermo Fisher Scientific
• Immucor

This report presents a comprehensive overview, market shares, and growth opportunities of HLA Antigen Typing and Antibody Detection market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antigen Typing
• Antibody Testing

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

1. Americas
   • United States
   • Canada
   • Mexico
   • Brazil
2. APAC
   • China
   • Japan
   • Korea
   • Southeast Asia
   • India
   • Australia
3. Europe
   • Germany
   • France
   • UK
   • Italy
   • Russia
4. Middle East & Africa
   • Egypt
   • South Africa
   • Israel
   • Turkey
   • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• Siemens
• Roche
• Thermo Fisher Scientific
• Immucor
• CareDx
• Natera
• Eurofins Scientific
• Medix Biochemica
• GENDX
• CGT Global
• Beckman Coulter